Samuel Denmeade

WikiDoc Resources for Samuel Denmeade
Articles
Most recent articles on Samuel Denmeade Most cited articles on Samuel Denmeade Review articles on Samuel Denmeade Articles on Samuel Denmeade in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Samuel Denmeade Images of Samuel Denmeade Photos of Samuel Denmeade Podcasts & MP3s on Samuel Denmeade Videos on Samuel Denmeade
Evidence Based Medicine
Cochrane Collaboration on Samuel Denmeade Bandolier on Samuel Denmeade TRIP on Samuel Denmeade
Clinical Trials
Ongoing Trials on Samuel Denmeade at Clinical Trials.gov Trial results on Samuel Denmeade Clinical Trials on Samuel Denmeade at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Samuel Denmeade NICE Guidance on Samuel Denmeade NHS PRODIGY Guidance FDA on Samuel Denmeade CDC on Samuel Denmeade
Books
Books on Samuel Denmeade
News
Samuel Denmeade in the news Be alerted to news on Samuel Denmeade News trends on Samuel Denmeade
Commentary
Blogs on Samuel Denmeade
Definitions
Definitions of Samuel Denmeade
Patient Resources / Community
Patient resources on Samuel Denmeade Discussion groups on Samuel Denmeade Patient Handouts on Samuel Denmeade Directions to Hospitals Treating Samuel Denmeade Risk calculators and risk factors for Samuel Denmeade
Healthcare Provider Resources
Symptoms of Samuel Denmeade Causes & Risk Factors for Samuel Denmeade Diagnostic studies for Samuel Denmeade Treatment of Samuel Denmeade
Continuing Medical Education (CME)
CME Programs on Samuel Denmeade
International
Samuel Denmeade en Espanol Samuel Denmeade en Francais
Business
Samuel Denmeade in the Marketplace Patents on Samuel Denmeade
Experimental / Informatics
List of terms related to Samuel Denmeade

Overview

Dr. Samuel Ray Denmeade is an oncologist at the Johns Hopkins University School of Medicine.

In addition to being an oncologist, he maintains an active research interest in novel ways to treat prostate cancer. He has been a key researcher in a number of cancer treatments, including engineering the bacterial toxin Aerolysin to target cancer cells. Other research includes the study of proteases, with the theory that a lethal drug could be disguised as a prodrug and only released when exposed to the enzymatic activity of PSA, PSA being present in its enzymatically active form only in the tumor and not elsewhere in the body.

External links

• Biography
• [http://www.protoxtherapeutics.com/102504.php Protox therapeutics press release,